Medications

Over 700 million shekels worth of medications are discarded annually in Israel while patients struggle to afford treatments, highlighting regulatory gaps between HMO collection bins and NGOs.

A new USC study published in JAMA reveals that over 20% of older American adults remain at risk for potential drug interactions despite slight decreases in rates.

Hundreds of patients filed lawsuits against GLP-1 drug makers Novo Nordisk and Eli Lilly, alleging sudden vision loss linked to medications like Ozempic and Mounjaro.

A check by Ha-Tzinor on Channel 13 reveals that consumers pay tens of percent more for well-known brands, while equivalent products with the same active ingredient are sold at much lower prices.